✦ LIBER ✦

DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma

✍ Scribed by Joseph-Pietras, D; Gao, Y; Zojer, N; Ait-Tahar, K; Banham, A H; Pulford, K; Rice, J; Savelyeva, N; Sahota, S S

Book ID: 109887239
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 725 KB
Volume: 24
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2010.196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytolytic T-cell response to the PASD1 c

Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma

✍ Kamel Ait-Tahar; Amanda P. Liggins; Graham P. Collins; Andrew Campbell; Martin B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

MAGE-C1/CT7 is the dominant cancer-testi

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma

✍ Curioni-Fontecedro, A; Knights, A J; Tinguely, M; Nuber, N; Schneider, C; Thomso 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Dominant responses with conservation of

Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma

✍ Oliver C. Goodyear; Hayden Pearce; Guy Pratt; Paul Moss 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 339 KB

Multiple mechanisms of action of ZR2002

Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA

✍ Fouad Brahimi; Zakaria Rachid; Qiyu Qiu; James P. McNamee; Yu-Jiang Li; Ana M. T 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB 👁 2 views

## Abstract The mechanism of action of ZR2002, a chimeric amino quinazoline designed to possess mixed EGFR tyrosine kinase (TK) inhibitory and DNA targeting properties, was compared to those of ZR01, a reversible inhibitor of the same class and PD168393, a known irreversible inhibitor of EGFR. ZR20